Judge Blocks Punitive Damages in Fossamax Claim Against Merck

By | August 31, 2011

  • August 31, 2011 at 2:22 pm
    DS says:
    Like or Dislike:
    Thumb up 0
    Thumb down 0

    Sounds like Merck has this judge in their pocket. “…said there was no evidence that Secrest’s prescribing doctor would have told her to stop using Fosamax in 2004 and 2005, at the time of her alleged injury, had Merck included a warning on its label.” …Really??

    “The judge also said punitive damages were inappropriate because no reasonable jury could conclude that Merck breached any legal duty either intentionally or with a “conscious disregard or indifference” to its customers’ health.”” …I’d want to see ALL the case studies and pharmaceutical trial results for this drug to see if Merck could have had a sliver of an idea that this could be a side effect before making such a statement. Hopefully the judge did a lot of homework before this.

  • August 31, 2011 at 2:45 pm
    Dee says:
    Like or Dislike:
    Thumb up 0
    Thumb down 0

    $926 million in current sales – wonder what the profit margin is for this drug? And that’s just one prescription drug out of thousands. Clearly the pharmaceutcal companies are very, very powerfully rich entities. They’re not going to voluntarily remove a highly profitable drug from the market and can easily afford to hire big gun lawyers to squash the lawsuits of the victims.

    I’ve had previous experience taking Fosamax, but quit several years ago after doing some research on my own. The side effects have diminished. It quite probably does more harm than good.



Add a Comment

Your email address will not be published. Required fields are marked *

*